We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OCUP market cap is 56.26M. The company's latest EPS is USD -0.3852 and P/E is -4.70.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.75M | 3.67M | 11.94M | 1.69M | 1.71M |
Operating Income | -6.13M | -5.39M | 6.39M | -5.43M | -7.71M |
Net Income | -5.79M | -4.96M | 5.56M | -4.8M | -7.11M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 589k | 39.85M | 19.05M |
Operating Income | -11.22M | -19.97M | -22.71M | 18.23M | -10.56M |
Net Income | -8.64M | -24.62M | -56.69M | 17.89M | -9.99M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 45.4M | 43.47M | 54.19M | 53.95M | 51.84M |
Total Liabilities | 4.15M | 5.76M | 3.91M | 4.04M | 5.79M |
Total Equity | 41.25M | 37.7M | 50.28M | 49.91M | 46.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.97M | 17.68M | 26.08M | 48.99M | 53.95M |
Total Liabilities | 3.01M | 31.15M | 3.86M | 2.75M | 4.04M |
Total Equity | 9.96M | -13.47M | 22.22M | 46.24M | 49.91M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.65M | -2.66M | -5.66M | -1.11M | -5.72M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | 5.38M | 8.98M | 2.38M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.28M | -6.8M | -19.37M | 14.31M | -1.11M |
Investing | 3.1M | 539k | -100k | N/A | N/A |
Financing | 7.65M | 21.12M | 27.61M | 3.79M | 8.98M |
Market Cap | 56.26M |
Price to Earnings Ratio | -4.70 |
Price to Sales Ratio | 2.46 |
Price to Cash Ratio | 0.93 |
Price to Book Ratio | 0.94 |
Dividend Yield | - |
Shares Outstanding | 25.92M |
Average Volume (1 week) | 105.57k |
Average Volume (1 Month) | 158.05k |
52 Week Change | -46.29% |
52 Week High | 4.50 |
52 Week Low | 1.50 |
Spread (Intraday) | 0.08 (3.77%) |
Company Name | Ocuphire Pharma Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.ocuphire.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions